001     131718
005     20240229105009.0
024 7 _ |a 10.1002/ijc.31047
|2 doi
024 7 _ |a pmid:28913878
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:26672614
|2 altmetric
037 _ _ |a DKFZ-2018-00024
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Campa, Daniele
|0 0000-0003-3220-9944
|b 0
245 _ _ |a Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
260 _ _ |a Bognor Regis
|c 2018
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1659538853_29253
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive tumor with a five-year survival of less than 6%. Chronic pancreatitis (CP), an inflammatory process in of the pancreas, is a strong risk factor for PDAC. Several genetic polymorphisms have been discovered as susceptibility loci for both CP and PDAC. Since CP and PDAC share a consistent number of epidemiologic risk factors, the aim of this study was to investigate whether specific CP risk loci also contribute to PDAC susceptibility. We selected five common SNPs (rs11988997, rs379742, rs10273639, rs2995271 and rs12688220) that were identified as susceptibility markers for CP and analyzed them in 2,914 PDAC cases, 356 CP cases and 5,596 controls retrospectively collected in the context of the international PANDoRA consortium. We found a weak association between the minor allele of the PRSS1-PRSS2-rs10273639 and an increased risk of developing PDAC (ORhomozygous  = 1.19, 95% CI 1.02-1.38, p = 0.023). Additionally all the SNPs confirmed statistically significant associations with risk of developing CP, the strongest being PRSS1-PRSS2-rs10273639 (ORheterozygous  = 0.51, 95% CI 0.39-0.67, p = 1.10 × 10-6 ) and MORC4-rs 12837024 (ORhomozygous  = 2.07 (1.55-2.77, ptrend  = 0.7 × 10-11 ). Taken together, the results from our study do not support variants rs11988997, rs379742, rs10273639, rs2995271 and rs12688220 as strong predictors of PDAC risk, but further support the role of these SNPs in CP susceptibility. Our study suggests that CP and PDAC probably do not share genetic susceptibility, at least in terms of high frequency variants.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Biomarkers, Tumor
|2 NLM Chemicals
650 _ 7 |a MORC4 protein, human
|2 NLM Chemicals
650 _ 7 |a Nuclear Proteins
|2 NLM Chemicals
650 _ 7 |a PRSS2 protein, human
|0 103964-84-7
|2 NLM Chemicals
650 _ 7 |a Trypsinogen
|0 9002-08-8
|2 NLM Chemicals
650 _ 7 |a PRSS1 protein, human
|0 EC 3.4.21.4
|2 NLM Chemicals
650 _ 7 |a Trypsin
|0 EC 3.4.21.4
|2 NLM Chemicals
700 1 _ |a Pastore, Manuela
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Capurso, Gabriele
|b 2
700 1 _ |a Hackert, Thilo
|b 3
700 1 _ |a Di Leo, Milena
|b 4
700 1 _ |a Izbicki, Jakob R
|b 5
700 1 _ |a Khaw, Kay-Tee
|b 6
700 1 _ |a Gioffreda, Domenica
|b 7
700 1 _ |a Kupcinskas, Juozas
|b 8
700 1 _ |a Pasquali, Claudio
|b 9
700 1 _ |a Macinga, Peter
|b 10
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 11
700 1 _ |a Stigliano, Serena
|b 12
700 1 _ |a Peeters, Petra H
|b 13
700 1 _ |a Key, Timothy J
|b 14
700 1 _ |a Talar-Wojnarowska, Renata
|b 15
700 1 _ |a Vodicka, Pavel
|b 16
700 1 _ |a Valente, Roberto
|b 17
700 1 _ |a Vashist, Yogesh K
|b 18
700 1 _ |a Salvia, Roberto
|b 19
700 1 _ |a Papaconstantinou, Ioannis
|b 20
700 1 _ |a Shimizu, Yasuhiro
|b 21
700 1 _ |a Valsuani, Chiara
|b 22
700 1 _ |a Zambon, Carlo Federico
|b 23
700 1 _ |a Gazouli, Maria
|b 24
700 1 _ |a Valantiene, Irena
|b 25
700 1 _ |a Niesen, Willem
|b 26
700 1 _ |a Mohelnikova-Duchonova, Beatrice
|b 27
700 1 _ |a Hara, Kazuo
|b 28
700 1 _ |a Soucek, Pavel
|0 0000-0002-4294-6799
|b 29
700 1 _ |a Malecka-Panas, Ewa
|b 30
700 1 _ |a Bueno-de-Mesquita, H B As
|b 31
700 1 _ |a Johnson, Theron Scot
|0 P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa
|b 32
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 33
700 1 _ |a Tavano, Francesca
|b 34
700 1 _ |a Fogar, Paola
|b 35
700 1 _ |a Ito, Hidemi
|0 0000-0002-8023-4581
|b 36
700 1 _ |a Sperti, Cosimo
|b 37
700 1 _ |a Butterbach, Katja
|0 P:(DE-He78)7ca7eafba864e5c3ebb7598149380452
|b 38
700 1 _ |a Latiano, Anna
|b 39
700 1 _ |a Andriulli, Angelo
|b 40
700 1 _ |a Cavestro, Giulia Martina
|b 41
700 1 _ |a Busch, Olivier R C
|b 42
700 1 _ |a Dijk, Frederike
|b 43
700 1 _ |a Greenhalf, William
|b 44
700 1 _ |a Matsuo, Keitaro
|0 0000-0003-1761-6314
|b 45
700 1 _ |a Lombardo, Carlo
|b 46
700 1 _ |a Strobel, Oliver
|b 47
700 1 _ |a König, Anna-Katharina
|b 48
700 1 _ |a Cuk, Katarina
|0 P:(DE-He78)0a8ada1f5d2ea05fc3af10cd808bfa9a
|b 49
700 1 _ |a Strothmann, Hendrik
|b 50
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 51
700 1 _ |a Cantore, Maurizio
|b 52
700 1 _ |a Mambrini, Andrea
|b 53
700 1 _ |a Oliverius, Martin
|b 54
700 1 _ |a Pezzilli, Raffaele
|b 55
700 1 _ |a Landi, Stefano
|b 56
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 57
|e Last author
|u dkfz
773 _ _ |a 10.1002/ijc.31047
|g Vol. 142, no. 2, p. 290 - 296
|0 PERI:(DE-600)1474822-8
|n 2
|p 290 - 296
|t International journal of cancer
|v 142
|y 2018
|x 0020-7136
909 C O |p VDB
|o oai:inrepo02.dkfz.de:131718
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 0
|6 0000-0003-3220-9944
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 38
|6 P:(DE-He78)7ca7eafba864e5c3ebb7598149380452
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 49
|6 P:(DE-He78)0a8ada1f5d2ea05fc3af10cd808bfa9a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 51
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 57
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2015
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 1
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 2
920 1 _ |0 I:(DE-He78)G110-20160331
|k G110
|l Präventive Onkologie
|x 3
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)G110-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21